Meeting
Abstract Number: 117
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Bisphosphonates are the most commonly prescribed medications for treatment for osteoporosis (OP). Although increasing evidence supports a good safety profile, there is an emerging concern regarding the cardiovascular safety of these agents. Whereas the association with superficial phlebitis has been well documented, the risk of VTE is still not established. Limited data exist on […]
Abstract Number: 277
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Osteoporosis is common and carries a significant burden of morbidity and mortality. Early pharmacologic therapy for osteoporosis can reduce osteoporotic fractures. Thus, the USPSTF recommends dual energy x-ray absorptiometry (DXA) screening for osteoporosis in women above the age of 65. Screening for osteoporosis is often seen as a responsibility of the primary care provider. […]